ResMed Increase (Decrease) in Accounts Receivable decreased by 76.8% to $16.86M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 57.9%, from $40.03M to $16.86M. Over 3 years (FY 2021 to FY 2025), Increase (Decrease) in Accounts Receivable shows a downward trend with a -16.0% CAGR.
An increase often signals rising sales or slower collections, while a decrease suggests improved collection efficiency or declining sales volume.
Measures the net change in amounts owed to the company by customers for goods or services delivered on credit. It reflec...
A fundamental working capital metric used by all companies to assess cash conversion cycles.
other_increase_decrease_in_accounts_receivable| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $89.30M | -$33.70M | -$48.77M | -$15.69M | $56.24M | $19.59M | $12.63M | $18.06M | -$6.53M | $26.80M | $56.49M | $57.52M | -$36.42M | $67.85M | $40.03M | $5.22M | -$29.97M | $72.68M | $16.86M |
| QoQ Change | — | -137.7% | -44.7% | +67.8% | +458.5% | -65.2% | -35.5% | +43.0% | -136.2% | +510.2% | +110.7% | +1.8% | -163.3% | +286.3% | -41.0% | -87.0% | -674.7% | +342.5% | -76.8% |
| YoY Change | — | — | — | — | +266.9% | +140.2% | +180.5% | — | -111.6% | +36.9% | +347.3% | +218.5% | -457.3% | +153.2% | -29.1% | -90.9% | +17.7% | +7.1% | -57.9% |